Drug Patents owned by Nuvo Pharms Inc

1. List of Pennsaid drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8217078 NUVO PHARMS INC Treatment of pain with topical diclofenac
Jul, 2029

(6 years from now)

US8618164 NUVO PHARMS INC Treatment of pain with topical diclofenac compounds
Jul, 2029

(6 years from now)

US8741956 NUVO PHARMS INC Treatment of pain with topical diclofenac
Jul, 2029

(6 years from now)

US8546450 NUVO PHARMS INC Treatment of pain with topical diclofenac compounds
Aug, 2030

(7 years from now)

Drugs and Companies using DICLOFENAC SODIUM ingredient

Market Authorisation Date: 04 November, 2009

Treatment: Use of topical diclofenac on the knee and a second topical medication on the same knee; Use of topical diclofenac on the knee and a second topical prescription medication on the same knee; Combination use of topical diclofenac on the knee and administration of an oral nsaid.; Use of topical diclofenac on the knee and a second topical agent selected from sunscreen and insect repellant

Dosage: SOLUTION;TOPICAL

How can I launch a generic of PENNSAID before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic